Human iPSC-derived mesoangioblasts, like their tissue-derived counterparts, suppress T cell proliferation through IDO- and PGE-2-dependent pathways [v1; ref status: indexed, http://f1000r.es/x3]
Human mesoangioblasts are currently in a phase I/II clinical trial for the treatment of patients with Duchenne muscular dystrophy. However, limitations associated with the finite life span of these cells combined with the significant numbers of mesoangioblasts required to treat all of the skeletal m...
Main Authors: | Ou Li, Karen English, Rossana Tonlorenzi, Giulio Cossu, Francesco Saverio Tedesco, Kathryn J Wood |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2013-01-01
|
Series: | F1000Research |
Subjects: | |
Online Access: | http://f1000research.com/articles/2-24/v1 |
Similar Items
-
Injectable polyethylene glycol-fibrinogen hydrogel adjuvant improves survival and differentiation of transplanted mesoangioblasts in acute and chronic skeletal-muscle degeneration
by: Fuoco Claudia, et al.
Published: (2012-11-01) -
Drosophila's contribution to stem cell research [v1; ref status: indexed, http://f1000r.es/5h7]
by: Gyanesh Singh
Published: (2015-06-01) -
Interactome Analysis of iPSC Secretome and Its Effect on Macrophages In Vitro
by: Luca Tamò, et al.
Published: (2021-01-01) -
Considerations in hiPSC-derived cartilage for articular cartilage repair
by: Akihiro Yamashita, et al.
Published: (2018-10-01) -
Assessing the bipotency of in vitro-derived neuromesodermal progenitors [v1; ref status: indexed, http://f1000r.es/58z]
by: Anestis Tsakiridis, et al.
Published: (2015-04-01)